N-acetylcysteine inhibits peroxynitrite-mediated damage in oleic acid-induced lung injury

Pulm Pharmacol Ther. 2004;17(5):263-70. doi: 10.1016/j.pupt.2004.05.002.

Abstract

Since oleic acid (OA) induces morphologic and cellular changes similar to those observed in human acute lung injury (ALI) and acute respiratory distress syndrome, it has become a widely used model to investigate the effects of several agents on pathogenesis of lung injury. The antioxidant and anti-inflammatory properties of N-acetylcysteine (NAC) has been documented in many lung injury models. In this study, we evaluated the role of NAC in an OA-induced lung injury model by measuring myeloperoxidase (MPO) activity, malondialdehyde (MDA) and 3-nitrotyrosine (3-NT) levels in lung tissue. Five groups labelled Sham, NAC, OA, Pre-OA-NAC and Post-OA-NAC were determined. ALI was induced by intravenous administration of OA. The pre-OA-NAC group received iv NAC 15 min before OA infusion and the post-OA-NAC group received iv NAC 2 h after OA infusion. In both of the NAC treatment groups' blood and tissue samples were collected 4 h after OA infusion, independent from the time of NAC infusion. The MPO activity, MDA and 3-NT levels in lung homogenates were found to be increased in OA group and the administration of NAC significantly reduced tissue MPO, MDA and 3-NT levels (p = 0.0001) Lung histopathology was also affected by NAC in this OA-induced experimental lung injury model.

MeSH terms

  • Acetylcysteine / pharmacology*
  • Animals
  • Female
  • Lung / drug effects
  • Lung / metabolism*
  • Lung / pathology*
  • Malondialdehyde / metabolism
  • Microscopy
  • Oleic Acid / adverse effects*
  • Peroxidase / metabolism
  • Peroxynitrous Acid / metabolism
  • Rats
  • Rats, Wistar
  • Tyrosine / analogs & derivatives*
  • Tyrosine / metabolism

Substances

  • Peroxynitrous Acid
  • Oleic Acid
  • 3-nitrotyrosine
  • Tyrosine
  • Malondialdehyde
  • Peroxidase
  • Acetylcysteine